Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast
- 14 February 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 194 (1) , 35-42
- https://doi.org/10.1002/path.838
Abstract
In order to understand the intricate relationship of cell proliferation and apoptosis in tumour development, proliferation markers (Ki‐67 and c‐myc), apoptosis, cell‐cycle inducers cyclin D1 and D3, and cell‐cycle inhibitors p16INK4, p21CIP1, and p27KIP1 were evaluated in ductal breast carcinoma. The heterogeneous nature of breast tumours provides a system by which the changes in cell‐cycle genes can be explored under a wide range of proliferation and apoptotic indices. To address the above issues, immunohistochemical studies were conducted in 40 pairs of tumours and adjacent normal ductal tissues. The TUNEL method was used to identify apoptotic cells. Except for p27/KIP1, the proliferation (Ki‐67, c‐myc) and the apoptotic indexes together with levels of p16/INK4a, p21/CIP1, cyclin D1, and cyclin D3, were clearly elevated among tumour tissues, while absent in the adjacent normal tissues. Spearman correlation analysis indicated strong associations among apoptotic index, Ki‐67, c‐myc, and tumour grade. In addition, p21/CIP1 and cyclin D3 were positively correlated, while p16/INK4a, p27/KIP1, and cyclin D1 were negatively correlated with tumour grade. There was clear decoupling between p21 and p27, as well as decoupling between cyclin D1 and cyclin D3, in terms of their relationship to cell proliferation and apoptosis, indicating differential roles in tumour progression. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Prognostic significance of Ki‐67 and topoisomerase IIα expression in infiltrating ductal carcinoma of the breastBreast Cancer Research and Treatment, 1999
- The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human CancerAnnual Review of Medicine, 1999
- Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1Genes & Development, 1998
- Re-expression of p16INK4a in mesothelioma cells results in cell cycle arrest, cell death, tumor suppression and tumor regressionOncogene, 1998
- Hypomethylation and increased gene expression of p16INK4a in primary and metastatic breast carcinoma as compared to normal breast tissueOncogene, 1998
- New functional activities for the p21 family of CDK inhibitors.Genes & Development, 1997
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Cancer Cell CyclesScience, 1996
- The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors.Genes & Development, 1996
- Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancerPathology - Research and Practice, 1993